http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#head http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#assertion http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#provenance http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#publicationInfo http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#assertion http://bio2rdf.org/drugbank:DB00196 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00196_DB08895 http://bio2rdf.org/drugbank:DB08895 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00196_DB08895 http://bio2rdf.org/drugbank_resource:DB00196_DB08895 http://purl.org/dc/terms/identifier drugbank_resource:DB00196_DB08895 http://bio2rdf.org/drugbank_resource:DB00196_DB08895 http://purl.org/dc/terms/title DDI between Fluconazole and Tofacitinib - Fluconazole (and other strong CYP2C19 inhibitors and moderate CYP3A4 inhibitors), when used in combination with tofacitinib, may increase tofacitinib concentration. It is recommended to modify therapy by reducing the adult dose of tofacitinib from 5mg twice a day to 5mg daily. http://bio2rdf.org/drugbank_resource:DB00196_DB08895 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00196_DB08895 http://www.w3.org/2000/01/rdf-schema#label DDI between Fluconazole and Tofacitinib - Fluconazole (and other strong CYP2C19 inhibitors and moderate CYP3A4 inhibitors), when used in combination with tofacitinib, may increase tofacitinib concentration. It is recommended to modify therapy by reducing the adult dose of tofacitinib from 5mg twice a day to 5mg daily. [drugbank_resource:DB00196_DB08895] http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#provenance http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#publicationInfo http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#signature.MC4CFQCNrthghkIR http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#signature.MC4CFQCNrthghkIR http://purl.org/nanopub/x/hasSignature MC4CFQCNrthghkIR319UqEdnSA3qqI0oHAIVAIKFEGBmiBMdLP8BL0njBAygBqUU http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#signature.MC4CFQCNrthghkIR http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://purl.org/dc/terms/created 2018-03-30T11:12:42.983+02:00 http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ#signature.MC4CFQCNrthghkIR http://bio2rdf.org/drugbank_resource:DB00196_DB08895_nanopub.RAVVjAOg20XdvFiJYPVjro6K60yeFaBteTQKesWmDumgQ http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234